Rebecsinib Clinical Trial Means New Options for Blood Cancer
A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego.
Science & Environment
The Latest
Nobel Laureate and UC San Diego Alumnus Susumu Tonegawa (1939-2026)
Susumu Tonegawa, who made key contributions to immunology and neurobiology and became UC San Diego’s first alumnus to receive a Nobel Prize, passed away on July 11. His research resolved a long-standing puzzle about how the immune system generates millions of antibodies from a small set of genes.
UC San Diego Students Learn Spatial Data Science Through Real-World Applications
UC San Diego students are bridging GIS and machine learning to solve real-world challenges in public health and urban planning. In a new spatial analysis course, they analyze complex geospatial data to identify environmental risks and support smarter community decision-making.
NSF Funds Major Center at UC San Diego to Make New Quantum Materials
The U.S. National Science Foundation (NSF) has awarded University of California San Diego researchers a six-year $18M grant to fund a Materials Research Science and Engineering Center (MRSEC) focused on making new kinds of quantum materials.
UC San Diego Researchers Use SDSC’s Expanse to Better Understand Bone-Like Minerals
Hydroxyapatite is already widely used in medical materials to help strengthen teeth and bones, since it is the primary mineral naturally found in bone. Researchers introduced europium’s light-emitting properties to make the material easier to see in bioimaging applications.
UC San Diego’s FY26 Awards Reflect Larger Grants in a More Competitive Landscape
University of California San Diego’s fiscal year 2026 awards totaled nearly $1.8 billion. Though the tally represents one of the university’s highest sponsored research totals, it reflects both momentum and caution in the research funding landscape.
Trending Stories
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
